Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease.
about
The Comorbidity of Major Depression and Anxiety Disorders: Recognition and Management in Primary CareEffects of Parkinson's Disease on Fundamental Frequency Variability in Running SpeechMemory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.Startle reflex hyporeactivity in Parkinson's disease: an emotion-specific or arousal-modulated deficit?Depression Reduces Accuracy While Parkinsonism Slows Response Time for Processing Positive Feedback in Patients with Parkinson's Disease with Comorbid Major Depressive Disorder Tested on a Probabilistic Category-Learning Task.Effects of depression and social support on comprehension and recall of informed consent information among Parkinson disease patients and their caregiversInfluence of depressive symptoms on dopaminergic treatment of Parkinson's diseaseDepression and Parkinson's disease: current knowledge.Depression rating scales in Parkinson's disease: critique and recommendations.The measurement, causes and effective management of cancer-related fatigue.The neuropathological basis for depression in Parkinson's disease.Regional homogeneity abnormalities affected by depressive symptoms in migraine patients without aura: a resting state study.Dementia with Lewy bodies: clinical characteristics and diagnostic criteria.Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson diseaseThe role of cognitive-behavioural therapy for patients with depression in Parkinson's disease.What are the determinants of quality of life in people with cervical dystonia?Neuropsychiatric non-motor aspects of Parkinson's disease.Cognitive profiles in Mild Cognitive Impairment (MCI) patients associated with Parkinson's disease and cognitive disordersHealth-related quality of life in Parkinson's disease: a cross-sectional study focusing on non-motor symptoms.A comparison of nine scales to detect depression in Parkinson disease: which scale to use?Antidepressant studies in Parkinson's disease: a review and meta-analysis.Depression in veterans with Parkinson's disease: frequency, co-morbidity, and healthcare utilizationAntidepressant treatment of veterans with Parkinson's disease and depression: analysis of a national sampleA matter of motion or an emotional matter? Management of depression in Parkinson's disease.Motor symptoms at onset of Parkinson disease and risk for cognitive impairment and depressionComponents of depression in Parkinson disease.Pattern of depressive symptoms in Parkinson's disease.Conceptualization of depression in Parkinson's diseaseEmotional state affects gait initiation in individuals with Parkinson's disease.Depression in Parkinson's disease: health risks, etiology, and treatment options.Suicidal and death ideation in Parkinson's disease.Attitudes regarding the etiology and treatment of depression in Parkinson's disease: a qualitative study.Dopaminergic modulation of memory and affective processing in Parkinson depression.Validity of the Cornell scale for depression in dementia in Parkinson's disease with and without cognitive impairment.Treatment of dementia with lewy bodiesProfile of idiopathic parkinson's disease in Moroccan patients.Treatment of depressive symptoms in Parkinson's disease.Cytokines as biomarkers in depressive disorder: current standing and prospects.Neural and behavioral substrates of subtypes of Parkinson's disease.Preconditioning as a potential strategy for the prevention of Parkinson's disease.
P2860
Q24682953-4BE78AED-CC03-49C2-BADA-FC6F4A4210B8Q30415709-96EE00BF-32DE-4E07-9CC4-84EE4AB597DCQ30470435-0BDE58F0-1E3F-47F9-B9A9-5195FABD0555Q30480822-D4873128-ECE5-4334-A270-6C88246CB764Q33785754-65F40DAD-916F-4FE5-A8EB-B02F7945D5E8Q34102890-C463C3EC-6E9D-44F5-A270-7847D3733231Q34242604-C46212B8-450E-431B-821E-2692FCD9B5C8Q34382560-F3BBC03D-D8CC-4403-AF26-3D554277619FQ34578187-A0252E3A-DB4C-475F-8127-DD5BBB4147CAQ34581994-1164776C-9837-4D81-895D-CDC95D8B90BFQ34764454-276A6561-A16F-482E-A16C-B01D80704B79Q35023489-13E1C5F4-2503-46BE-A52D-A553730D5428Q35029466-B3DA93F1-5F97-4841-A6CB-94A958E2CAFFQ35040826-374A642E-A8B5-4DE0-A601-7856C1BF087DQ35101458-453F6932-CDAC-49E2-8B6F-ED9CA344A9A0Q35466924-13B6E372-AEAE-4111-AA3E-3E9BB7F08D8EQ35518017-9B894C50-A82B-4238-9612-769704062C05Q35651852-041A5864-6B61-4DAB-9EF2-F0CA11611395Q35761258-0F569588-2BDA-4153-9B16-7BBFEBDC4FA3Q35846532-4184850D-E9FC-41A6-BEEB-7064D9FF56C1Q36008775-EDA7E802-90C0-4F39-AFBA-54A5605B3625Q36024004-B387B973-5CF1-4949-852C-8F6DCDE4C416Q36026290-50AF1571-1FBE-442C-9315-134EAF911A01Q36307871-141BA5E8-C352-427B-8792-C1348093CE88Q36336894-5B773C4F-7171-4F98-9D77-1D3F87855D3AQ36374392-0BF2A3AA-3DD9-4E98-9C52-D9BDAFE1646BQ36485545-A9AE85C5-CCE2-42DA-BB26-AE83C58D825AQ36700296-A19310C7-790D-4B4F-919A-8DA6AE42B813Q36744761-8C30C258-80F3-4022-BD00-EE17A47B28BBQ36836774-7DAF383A-5FFB-4E6A-B90E-CE9219E29121Q37084012-B3EAC395-3BAA-4EA4-9346-9EABA31717A2Q37187592-A411AC4A-B20B-4BC6-A51A-7648586BAEF5Q37248904-3289684E-B0BE-41A8-A347-E01423B94C24Q37302848-BCD05367-3D18-4064-958A-E06692440C99Q37552865-EB743DB6-5948-489E-A1E5-F49FFD16AC55Q37624971-AC6263B2-E196-4D29-958A-489CC39F6439Q37831398-3026309A-2C98-4C60-AD3B-4334D4284BF3Q38154918-B3A061BC-90BD-4613-B426-2A5EE8439CC8Q38176606-C6DB4639-A631-468F-95DF-4E469DF0E9C9Q38201685-A0A3A9FD-DF41-4C32-BB2E-D29E69E210C4
P2860
Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Prevalence, clinical manifesta ...... ession in Parkinson's disease.
@ast
Prevalence, clinical manifesta ...... ession in Parkinson's disease.
@en
Prevalence, clinical manifesta ...... ession in Parkinson's disease.
@nl
type
label
Prevalence, clinical manifesta ...... ession in Parkinson's disease.
@ast
Prevalence, clinical manifesta ...... ession in Parkinson's disease.
@en
Prevalence, clinical manifesta ...... ession in Parkinson's disease.
@nl
prefLabel
Prevalence, clinical manifesta ...... ession in Parkinson's disease.
@ast
Prevalence, clinical manifesta ...... ession in Parkinson's disease.
@en
Prevalence, clinical manifesta ...... ession in Parkinson's disease.
@nl
P2093
P356
P1476
Prevalence, clinical manifesta ...... ession in Parkinson's disease.
@en
P2093
Martens MP
Slaughter JR
Slaughter KA
P304
P356
10.1176/JNP.13.2.187
P577
2001-01-01T00:00:00Z